Subject(s)

Antimetabolites, Antineoplastic/therapeutic use , Azacitidine/therapeutic use , Leukemia, Myelomonocytic, Chronic/drug therapy , Skin Neoplasms/drug therapy , Administration, Cutaneous , Humans , Leukemia, Myelomonocytic, Chronic/genetics , Leukemia, Myelomonocytic, Chronic/pathology , Lip Neoplasms/drug therapy , Lip Neoplasms/genetics , Lip Neoplasms/pathology , Lip Neoplasms/radiotherapy , Male , Middle Aged , Skin Neoplasms/genetics , Skin Neoplasms/pathology